CI-1040 in Treating Patients With Advanced Breast, Colon, Pancreatic, or Non-Small Cell Lung Cancer

NCT00033384 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Breast Cancer
Colorectal Cancer
Lung Cancer
Pancreatic Cancer

Interventions

DRUG: CI-1040

Sponsor

University of Alabama at Birmingham

Collaborators

[object Object]